JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.02090-06v1
45/5/1572    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delobel, P.
Right arrow Articles by Izopet, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delobel, P.
Right arrow Articles by Izopet, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2007, p. 1572-1580, Vol. 45, No. 5
0095-1137/07/$08.00+0     doi:10.1128/JCM.02090-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies{triangledown}

Pierre Delobel,1,2,3 Marie-Thérèse Nugeyre,2 Michelle Cazabat,1 Christophe Pasquier,1 Bruno Marchou,3 Patrice Massip,3 Françoise Barre-Sinoussi,2 Nicole Israël,2 and Jacques Izopet1*

Laboratoire de Virologie EA2046-IFR30, Centre Hospitalier Universitaire de Toulouse, 31059 Cedex 9, Toulouse, France,1 Unité de Régulation des Infections Rétrovirales, Institut Pasteur, 75724 Cedex 15, Paris, France,2 Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, 31059 Cedex 9, Toulouse, France3

Received 11 October 2006/ Returned for modification 17 November 2006/ Accepted 19 February 2007

Genotypic population-based methods could be faster and less expensive than phenotypic recombinant assays for determining human immunodeficiency virus type 1 (HIV-1) coreceptor usage in patient samples, but their clinical use requires good genotype-phenotype correlation and concordance with clonal analyses. We have assessed these requirements by clonal analysis of the V1 to V3 env PCR products of 26 patients infected with subtype B HIV-1. We used the resulting set of molecular clones, all sequenced and characterized using a single-cycle recombinant virus phenotypic entry assay, to reevaluate genotype-phenotype correlations. Combining the previously described 11/25 and net charge rules for the V3 genotype improved the prediction of HIV-1 coreceptor usage. We also evaluated the concordance of population-based and clonal analyses for predicting the coreceptor usage of HIV-1 quasispecies. Our population-based recombinant phenotypic assay and direct sequencing of V3 were similarly sensitive for detecting the presence of minor species in the virus population, and both correlated well with clonal analysis. The improved genotype-phenotype correlation obtained by combining two simple genotypic rules and the good concordance with clonal analyses suggest that direct sequencing of V3 is a valuable alternative to population-based recombinant phenotypic assays.


* Corresponding author. Mailing address: Laboratoire de Virologie EA2046-IFR30, Centre Hospitalier Universitaire de Toulouse, Hôpital Purpan, 330 Avenue de Grande-Bretagne, TSA 40031, 31059 Cedex 9, Toulouse, France. Phone: 33-5-67-69-04-24. Fax: 33-5-67-69-04-25. E-mail: izopet.j{at}chu-toulouse.fr

{triangledown} Published ahead of print on 28 February 2007.


Journal of Clinical Microbiology, May 2007, p. 1572-1580, Vol. 45, No. 5
0095-1137/07/$08.00+0     doi:10.1128/JCM.02090-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.